WhatsApp: A Real-Time Tool to Reduce the Knowledge Gap and Share the Best Clinical Practices in Psoriasis.
None
Journal
Telemedicine journal and e-health : the official journal of the American Telemedicine Association
ISSN: 1556-3669
Titre abrégé: Telemed J E Health
Pays: United States
ID NLM: 100959949
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
21
6
2018
medline:
14
1
2020
entrez:
21
6
2018
Statut:
ppublish
Résumé
Psoriasis is a chronic inflammatory disease that affects around 100 million people worldwide. The burden of disease is high, but more recent therapies show promising results. Clinicians need, however, more training in the use of such therapies. Project ECHO One hundred thirty-two dermatologists in Argentina were invited to participate in the WhatsApp discussion group. After 1 year of participation, a follow-up questionnaire was used to assess the effectiveness of the project. Eighty dermatologists participated. All questions placed in the discussion were answered by a psoriasis specialist, 79% of which were answered within the first 5 min. Clinicians report significant improvement in diagnosis, comorbidities, and treatment with both conventional and biological therapies. Preliminary results are promising. This new cost-effective solution builds on the existing Project ECHO Psoriasis in Argentina and shows potential in bridging the gap of knowledge, promoting better clinical decisions through empowerment of medical doctors operating in remote locations. Further research is needed to increase generalization of the results. Moreover, it would be interesting to match the data from the discussion group with follow-up questionnaires.
Sections du résumé
BACKGROUND
Psoriasis is a chronic inflammatory disease that affects around 100 million people worldwide. The burden of disease is high, but more recent therapies show promising results. Clinicians need, however, more training in the use of such therapies.
INTRODUCTION
Project ECHO
MATERIALS AND METHODS
One hundred thirty-two dermatologists in Argentina were invited to participate in the WhatsApp discussion group. After 1 year of participation, a follow-up questionnaire was used to assess the effectiveness of the project.
RESULTS
Eighty dermatologists participated. All questions placed in the discussion were answered by a psoriasis specialist, 79% of which were answered within the first 5 min. Clinicians report significant improvement in diagnosis, comorbidities, and treatment with both conventional and biological therapies.
DISCUSSION
Preliminary results are promising. This new cost-effective solution builds on the existing Project ECHO Psoriasis in Argentina and shows potential in bridging the gap of knowledge, promoting better clinical decisions through empowerment of medical doctors operating in remote locations.
CONCLUSIONS
Further research is needed to increase generalization of the results. Moreover, it would be interesting to match the data from the discussion group with follow-up questionnaires.
Identifiants
pubmed: 29924684
doi: 10.1089/tmj.2018.0059
pmc: PMC6482902
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
294-300Références
Am J Clin Dermatol. 2005;6(6):383-92
pubmed: 16343026
BMJ Innov. 2017 Jul;3(3):144-151
pubmed: 29445515
Osteoporos Int. 2017 Jan;28(1):407-411
pubmed: 27439373
Turk J Gastroenterol. 2015 Nov;26(6):447-9
pubmed: 26510085
Br J Dermatol. 2007 Jun;156(6):1245-50
pubmed: 17459044
Rural Remote Health. 2015 Oct-Dec;15(4):3485
pubmed: 26625931
Med Educ Online. 2015 Dec 23;20:30593
pubmed: 26701841
Curr Psychiatry Rep. 2017 Sep 30;19(11):86
pubmed: 28965319
J Invest Dermatol. 2013 Feb;133(2):377-85
pubmed: 23014338
J Med Syst. 2016 Jun;40(6):130
pubmed: 27083574
J Contin Educ Health Prof. 2014 Winter;34(1):68-75
pubmed: 24648365
Pain Med. 2018 Jun 1;19(6):1140-1146
pubmed: 29036381
Pain Med. 2017 Oct 01;18(10):1882-1889
pubmed: 29044409
Dermatol Online J. 2016 Sep 15;22(9):
pubmed: 28329605
BMC Med Educ. 2017 Jan 6;17(1):7
pubmed: 28061777
Womens Health (Lond). 2016 Jan;12(1):79-81
pubmed: 26696393
Acad Med. 2007 Feb;82(2):154-60
pubmed: 17264693
Clin Exp Dermatol. 2001 Jun;26(4):314-20
pubmed: 11422182
Annu Rev Public Health. 2015 Mar 18;36:393-415
pubmed: 25785892
Medicina (B Aires). 2016;76(6):359-361
pubmed: 27959844
Public Health Rep. 2007;122 Suppl 2:74-7
pubmed: 17542458
Curr Diab Rep. 2016 Oct;16(10):96
pubmed: 27549110
BMJ Innov. 2016 Jul;2(3):109-110
pubmed: 27547446
Acad Med. 2014 Jan;89(1):30-2
pubmed: 24280860